ArticleJournal for immunotherapy of cancer2023

Antitumor activity of the investigational B7-H3 antibody-drug conjugate, vobramitamab duocarmazine, in preclinical models of neuroblastoma.

Chiara Brignole et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.